Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 2/20 | 0.37 |
| ▸ | CSNK1E | P49674 | 10/20 | 0.36 |
| ▸ | CSNK1D | P48730 | 6/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | CTSA | P10619 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1763152 | 0.91 | CSNK1E (0.43) | POLBCSNK1ECSNK1D | |
| SCHEMBL1763063 | 0.90 | MGLL (0.38) | POLBCSNK1ECSNK1DDHODHMGLL | |
| SCHEMBL3325668 | 0.87 | POLB (0.38) | POLBCTSA | |
| SCHEMBL1762881 | 0.84 | CSNK1D (0.41) | POLBCSNK1ECSNK1DDHODH | |
| SCHEMBL3329484 | 0.84 | CSNK1D (0.41) | POLBGRM5CSNK1ECSNK1DDHODH | |
| SCHEMBL1763226 | 0.84 | CSNK1E (0.41) | POLBCSNK1ECSNK1DDHODHMGLL | |
| SCHEMBL1762911 | 0.84 | POLB (0.36) | POLBCSNK1ECSNK1DDHODHMGLL | |
| SCHEMBL1762833 | 0.83 | PTGER4 (0.39) | POLBGRM5 | |
| SCHEMBL1762849 | 0.81 | HSD17B10 (0.44) | POLBCSNK1ECSNK1D | |
| SCHEMBL28930106 | 0.81 | GRM2 (0.39) | POLBCSNK1ECSNK1DPDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263327-B2 | Enzymatic method for the production of microcapsules | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-20110124590-A1 | Oil-in-Water Emulsion Comprising Solvent, Water, Surfactant and Pesticide | BASF SE (DE) | 2011-05-26 | — | — | US | disclosed |
| US-20100120617-A1 | Enzymatic Method for the Production of Microcapsules | BASF SE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120617-A1 | Enzymatic Method for the Production of Microcapsules | MGAM, ACHE, BCHE | POLB 565/4885GRM5 2191/4885CSNK1E 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.